Article
Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants.
Cardiovascular drugs and therapy - 1 Feb 2018
Tseng Andrew S, Patel Reema D, Quist Heidi E, Kekic Adrijana, Maddux Jacob T, Grilli Christopher B, Shamoun Fadi E
Abstract excerpt
PURPOSE: There is growing interest in the use of pharmacogenomics to optimize the safety and efficacy of anticoagulation therapy. While the pharmacogenomics of warfarin have been well-studied, the pharmacogenomics of direct oral anticoagulants (DOACs) continue to be a fledgling, but growing, field of interest. We present a pertinent clinical review of the present state of research on the pharmacogenomics of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.